(Total Views: 838)
Posted On: 10/10/2020 5:35:06 PM
Post# of 154320
The future of Leronlimab is for how long? If your following medical breakthroughs you have probably heard of Crispr? If not, you should research Crispr. As investors we need to know the science that could derail our investment.
I see Leronlimab as a gift to medicine but not the answer to everything and quite possible time limited to some degree. Leronlimab will always have a place and use when fully trialed for the many indications. This will be the biggest drug since penicillin as stated months ago by other posts. I believe this also.
This window of time is limited if Crispr progresses to approval and use. It’s been predicted that Crispr will be the medical breakthrough we all need to cure all future diseases. We are 10-15 years away from realizing those predictions as stated by a Harvard professor researching crispr.
In the mean time we have to progress Leronlimab for as many indications as possible to realize our investment. All indication may not be approved for use but many will and I remain hopeful. Once we hit revenue we need to progress through our indications as quickly as possible to fill that gap in time for treatment and new medicine before the cure to all diseases becomes commonplace. That’s what science is saying about gene editing. The cure for everything is in our future. As soon as we totally understand the DNA strand and how to safely edit it.
I see Leronlimab as a gift to medicine but not the answer to everything and quite possible time limited to some degree. Leronlimab will always have a place and use when fully trialed for the many indications. This will be the biggest drug since penicillin as stated months ago by other posts. I believe this also.
This window of time is limited if Crispr progresses to approval and use. It’s been predicted that Crispr will be the medical breakthrough we all need to cure all future diseases. We are 10-15 years away from realizing those predictions as stated by a Harvard professor researching crispr.
In the mean time we have to progress Leronlimab for as many indications as possible to realize our investment. All indication may not be approved for use but many will and I remain hopeful. Once we hit revenue we need to progress through our indications as quickly as possible to fill that gap in time for treatment and new medicine before the cure to all diseases becomes commonplace. That’s what science is saying about gene editing. The cure for everything is in our future. As soon as we totally understand the DNA strand and how to safely edit it.
(3)
(1)
